Vince O’Neill, Head of R&D, Mosaic Therapeutics, commented: “ I look forward to working closely with the Board and the team to advance our programs into the clinic and for the opportunity to develop ...

Researchers at National Jewish Health and collaborating institutions have uncovered a critical mechanism driving persistent ...

Pancreatic ductal adenocarcinoma is the most common type of pancreatic cancer and has a low five-year survival rate. It ...

Glioma remains one of the deadliest brain cancers, characterized by aggressive growth and limited treatment options. In a new study, researchers from Ningxia Medical University uncovered that choline ...

The March, 2026, decision by the French drug regulatory agency to approve intravenous racemic ketamine for the treatment of adult severe suicidal crisis1 represents a major step forward in the ...

A proprietary monoclonal antibody targeting an inhibitory immune checkpoint pathway had favorable safety and tolerability in ...